Shelf life (days): 1460
Info: A DNA methyltransferase inhibitor (IC50s = 9 and 2.8 µM for DNMT1 and the DNMT3A2/DNMT3L complex, respectively); selective for these DNMTs over PRMT1 and G9a-like protein; selectively decreases the viability of U937, Raji, PC3, and MDA-MB-231 cancer cells over isolated PBMCs (IC50s = 4.3, 8.8, 6.6, 9.7, and 57.4 µM, respectively); decreases tumor volume in a PDX mouse model of osteosarcoma at 50 mg/kg when used alone or in combination with doxorubicin
Formulation: A solid
Formal Name: N-[3-[(2-amino-6-methyl-4-pyrimidinyl)amino]phenyl]-3-(4-quinolinylamino)-benzamide
Purity: ≥98%
Formula Markup: C27H23N7O
Formula Weight: 461.529
CAS Number: 1535187-91-7